Skip to main content
Top

Diabetologia

Issue 8/2002

Content (14 Articles)

Article

l-arginine infusion decreases plasma total homocysteine concentrations through increased nitric oxide production and decreased oxidative status in Type II diabetic patients

M. Cassone Faldetta, O. Laurenti, G. Desideri, M. Bravi, O. De Luca, M. Marinucci, G. De Mattia, C. Ferri

Article

The effect of polyneuropathy on foot microcirculation in Type II diabetes

M. Nabuurs-Franssen, A. Houben, J. Tooke, N. Schaper

Article

Insulin signal transduction and glucose transport in human adipocytes: effects of obesity and low calorie diet

M. Björnholm, L. Al-Khalili, A. Dicker, E. Näslund, S. Rössner, J. Zierath, P. Arner

Article

Myocardial infarction in diabetic rats: role of hyperglycaemia on infarct size and early expression of hypoxia-inducible factor 1

R. Marfella, M. D'Amico, C. Di Filippo, E. Piegari, F. Nappo, K. Esposito, L. Berrino, F. Rossi, D. Giugliano

Article

The SstI polymorphism of the apo C-III gene is associated with insulin sensitivity in young men

F. Pérez-Jiménez, J. López-Miranda, P. Gómez, M. Velasco, C. Marín, P. Pérez-Martínez, J. Moreno, J. Paniagua

Review

Charcot neuroarthropathy in diabetes mellitus

S. Rajbhandari, R. Jenkins, C. Davies, S. Tesfaye

Article

Expression profile of MODY3/HNF-1α protein in the developing mouse pancreas

T. Nammo, K. Yamagata, R. Hamaoka, Q. Zhu, T. Akiyama, F. Gonzalez, J. Miyagawa, Y. Matsuzawa

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine